valine has been researched along with Venous Thrombosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Duan, J; Ji, X; Jiang, H; Li, M; Liu, L; Meng, R; Wei, H; Wu, Y; Xiao, X; Zhou, C; Zhou, Y | 1 |
Barosi, G; Bergamaschi, G; Carolei, A; Catarsi, P; Poletto, V; Primignani, M; Rosti, V; Spolverini, A; Vannucchi, AM; Villani, L | 1 |
Ariƫns, RA; Bertina, RM; Grant, PJ; Komanasin, N; Poort, SR; Rosendaal, FR; Van Hylckama Vlieg, A | 1 |
Francis, CW | 1 |
Rosendaal, FR; Vossen, CY | 1 |
Anderson, JL; Doucette, SP; Gagnon, F; Scarvelis, DK; Wells, PS | 1 |
Anderson, JL; Carson, N; Doucette, SP; Grimwood, RL; Rodger, MA; Wells, PS | 1 |
Amitrano, L; Brancaccio, V; Colaizzo, D; Grandone, E; Guardascione, MA; Margaglione, M; Scenna, G; Tiscia, GL | 1 |
2 review(s) available for valine and Venous Thrombosis
Article | Year |
---|---|
Factor XIII polymorphisms and venous thromboembolism.
Topics: Blood Coagulation Tests; Enzyme-Linked Immunosorbent Assay; Factor XIII; Fibrinolysis; Humans; Polymorphism, Genetic; Risk Factors; Thromboembolism; Thrombophilia; Valine; Venous Thrombosis | 2002 |
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Topics: Amino Acid Substitution; Factor XIII; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Leucine; Point Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Valine; Venous Thrombosis | 2006 |
6 other study(ies) available for valine and Venous Thrombosis
Article | Year |
---|---|
Potential role of plasma branched-chain amino acids in the differential diagnosis of acute cerebral venous thrombosis.
Topics: Amino Acids, Branched-Chain; Biomarkers; Diagnosis, Differential; Humans; Isoleucine; Leucine; Valine; Venous Thrombosis | 2023 |
JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms.
Topics: Bone Marrow Neoplasms; Case-Control Studies; Fusion Proteins, bcr-abl; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Janus Kinase 2; Mesenteric Vascular Occlusion; Mesenteric Veins; Mutation; Myeloproliferative Disorders; Phenylalanine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Splanchnic Circulation; Valine; Venous Thrombosis | 2012 |
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Factor XIII; Factor XIIIa; Female; Genotype; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Valine; Venous Thrombosis | 2002 |
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Case-Control Studies; Cross-Linking Reagents; Factor XIII; Female; Fibrinogen; Gene Frequency; Heterozygote; Homozygote; Humans; Leucine; Male; Middle Aged; Mutation; Odds Ratio; Risk; Valine; Venous Thrombosis | 2005 |
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Topics: Amino Acid Substitution; Case-Control Studies; Factor XIII; Female; Genetic Predisposition to Disease; Genotype; Humans; Leucine; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Assessment; Thromboembolism; Valine; Venous Thrombosis; White People | 2006 |
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cohort Studies; Female; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Janus Kinase 2; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Mutation; Myeloproliferative Disorders; Odds Ratio; Phenylalanine; Portal Vein; Risk Factors; Time Factors; Valine; Venous Thrombosis; Von Hippel-Lindau Tumor Suppressor Protein | 2007 |